Stockreport

The global anti-idiopathic pulmonary fibrosis drugs market is expected to grow at a CAGR of 16.7%

Zai Lab Limited - American Depositary Shares  (ZLAB) 
US:NASDAQ Investor Relations: zailaboratory.com/about/investors.php